%0 Journal Article %T Checking the absence of inflammatory activity with an objective marker, a key point to succeed the switch from intravenous to subcutaneous infliximab in inflammatory bowel disease %+ CHU Clermont-Ferrand %+ Infection Inflammation et Interaction Hôtes Pathogènes [CHU Clermont-Ferrand] (3IHP ) %+ Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH) %+ Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)) %+ Périnatalité et Risques Toxiques - UMR INERIS_I 1 (PERITOX) %+ Université de Picardie Jules Verne (UPJV) %A Buisson, Anthony %A Nachury, Maria %A Fumery, Mathurin %Z Letter %< avec comité de lecture %@ 1542-3565 %J Clinical Gastroenterology and Hepatology %I WB Saunders %8 2022-11 %D 2022 %R 10.1016/j.cgh.2022.11.006 %M 36402373 %Z Life Sciences [q-bio]/Human health and pathologyJournal articles %X No abstract available %G English %L hal-03870157 %U https://u-picardie.hal.science/hal-03870157 %~ INSERM %~ INERIS %~ PRES_CLERMONT %~ UNIV-PICARDIE %~ M2ISH %~ UNIV-LILLE %~ CHU-CLERMONTFERRAND %~ INRAE %~ U-PICARDIE %~ PERITOX %~ MICA-UNITES %~ TEST3-HALCNRS